跳至主要内容
临床试验/CTRI/2023/01/049022
CTRI/2023/01/049022尚未招募不适用

Evaluating the Role of LM Potency in Treatment of Tinea Cruris and Tinea Corporis in Rural Area.

Dr Jwalantkumar Prajapati1 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2023年1月16日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
50
试验地点
1
主要终点
To evaluate the effects of Homoeopathic Medicines in LM potency in the management of Tinea cruris and tinea corporis in rural areas.

研究概览

简要总结

Patients come with TINEA CRURIS AND TINEA CORPORIS mostfrequently for treatment in the dermatology OPD. Its prevalence is increasing day by day.  It is spread easily and fast to another person also. People are most bothered by this disease as it spread to any area of the body. Many times disease creates an embarrassing situation for patients.

Evenafter taking allopathic treatment from various Dermatologists and for a longerduration, there was no expected result. The disease remains hidden or silent forsome time and again comes back at the same location or a different location. The disease came back in a more vigorous form. Ultimately even after spending so much timeand money patient did not get permanent improvement.

The homoeopathic treatment avoids the recurrence of the disease, suppression of disease, and cures the disease from root.

研究设计

研究类型
Interventional
分配方式
Not Applicable
盲法
Not Applicable

入排标准

年龄范围
1.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Patients diagnosed with Tinea cruris or Tinea corporis or both Patients belong to any age group.

排除标准

  • k/c/o Comorbid Clinical conditions like DM, immunocompromised person, Cushing syndrome, on immunosuppression drugs.

结局指标

主要结局

To evaluate the effects of Homoeopathic Medicines in LM potency in the management of Tinea cruris and tinea corporis in rural areas.

时间窗: 12 weeks

次要结局

  • 1. To explore commonly coming Medicines in the treatment of tinea cruris and tinea corporis.

研究者

发起方
Dr Jwalantkumar Prajapati
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验